Table 3.
Results of associations between ASR phenotypes and NLRP3 inflammasome pathway SNPs in the DIOS cohort.
| SNP | A1/A2 | MAF | Fatigue |
Musculoskeletal Pain |
Mood disturbances |
Acute sickness |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F_Ca* | OR | 95% CI | F_Ca* | OR | 95% CI | F_Ca* | OR | 95% CI | F_Ca* | OR | 95% CI | |||
| rs35829419 | A/C | 0.051 | 0.105 | 13.3 | 1.7–104£ | 0.083 | 1.36 | 0.5–4.1 | 0.068 | 1.8 | 0.5–6.4 | 0.063 | 3.67 | 0.7–18.1 |
| rs10754558 | G/C | 0.415 | 0.368 | 1.16 | 0.7–1.9 | 0.447 | 1.7 | 0.9–3.1 | 0.323 | 0.68 | 0.4–1.2 | 0.418 | 1.16 | 0.7–2 |
| rs4848306 | A/G | 0.450 | 0.368 | 0.52 | 0.3–0.8 | 0.385 | 0.71 | 0.4–1.3 | 0.372 | 0.66 | 0.4–1.1 | 0.381 | 0.59 | 0.34–1 |
| rs16944 | A/G | 0.343 | 0.421 | 1.71 | 0.9–2.9 | 0.364 | 0.95 | 0.5–1.7 | 0.362 | 1.36 | 0.8–2.5 | 0.381 | 1.17 | 0.7–2 |
| rs360719 | G/A | 0.274 | 0.368 | 1.31 | 0.8–2.3 | 0.291 | 0.95 | 0.5–1.7 | 0.303 | 1.41 | 0.8–2.6 | 0.336 | 1.12 | 0.6–1.9 |
| rs5744292 | C/T | 0.241 | 0.236 | 0.83 | 0.5–1.5 | 0.291 | 1.38 | 0.7–2.6 | 0.205 | 1 | 0.5–1.9 | 0.272 | 0.91 | 0.6–1.9 |
| rs1946519 | A/C | 0.406 | 0.438 | 1.15 | 0.7–1.9 | 0.354 | 0.62 | 0.3–1.1 | 0.382 | 0.88 | 0.5–1.5 | 0.445 | 1.07 | 0.5–1.6 |
| rs501192 | T/C | 0.170 | 0.193 | 1.57 | 0.8–3.2 | 0.166 | 1.17 | 0.5–2.6 | 0.187 | 0.88 | 0.4–1.7 | 0.2 | 0.94 | 0.5–1.8 |
| rs2043211 | T/A | 0.331 | 0.271 | 0.616 | 0.4–1.1 | 0.375 | 0.95 | 0.5–1.7 | 0.372 | 1.18 | 0.7–2.1 | 0.336 | 0.73 | 0.4–1.3 |
A1 : minor alleles, A2 : major alleles; MAF: minor allele frequency. *F_Ca : allele frequency among cases. £ p = 0.015 is adjusted to the number of SNPs by a Bonferroni correction.